MedPath

The Evaluation of a Novel Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Device: Nasal Pillows CPAP mask
Registration Number
NCT03605485
Lead Sponsor
Fisher and Paykel Healthcare
Brief Summary

This investigation is a prospective, non randomized, non blinded study. This investigation is designed to evaluate the performance, comfort and ease of use with the F\&P trial nasal pillows mask amongst Obstructive Sleep Apnea (OSA) participants.

Detailed Description

Visit 1 will involve the participants consented in to the trial. Participants will be fitted with the F\&P trial nasal pillows mask for use in-lab.

The participant will then return the mask and have a interview, this ensures the maximum time participants will be exposed to the trial mask in lab will be in 1 night.

The mask will be returned to the Institution at the conclusion of the trial and the participant will return to their previous mask. The Institution will recruit all participants within 1 week of the beginning of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Adult (18+ years of age)
  • Able to give consent
  • Apnea hypopnea Index (AHI)≥ 5 on diagnostic night
  • Prescribed PAP for OSA
  • Existing nasal pillows mask user
Exclusion Criteria
  • Inability to give consent
  • Patients who are in a coma or a decreased level of consciousness
  • Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure)
  • Commercial drivers who are investigated by New Zealand Transport Agency
  • Current diagnosis of carbon dioxide (CO2) retention
  • Pregnant or may think they are pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Trial Continuous Positive Airway Pressure (CPAP) maskNasal Pillows CPAP maskTrial nasal pillows CPAP mask
Primary Outcome Measures
NameTimeMethod
Acceptability1 night

Subjective Questionnaire

Ease of use1 night

Subjective Questionnaire

Secondary Outcome Measures
NameTimeMethod
Objective Leak Data1 night

Data obtained from participant's device - Objective

Trial Locations

Locations (1)

Fisher & Paykel Helathcare

🇳🇿

Auckland, New Zealand

© Copyright 2025. All Rights Reserved by MedPath